自发性脑出血血肿扩大评分在亚洲患者队列中的外部验证
该研究在新加坡一家三级医院(认证卒中中心)前瞻纳入123例自发性脑出血患者,外部验证PREDICT、9分和BRAIN三种血肿扩大风险预测模型。对所有模型进行逻辑重新校准后,比较区分度(c统计量)、校准(Hosmer-Lemeshow检验、le Cessie-van Houwelingen-Copas-Hosmer检验、赤池信息准则)、整体表现(Brier评分、R2)和临床实用性(决策曲线分析)。结果显示,基于赤池信息准则和c统计量构成的新矩阵,重新校准的PREDICT评分表现最佳,R2最高(0.26)、Brier评分最低(0.14);决策曲线分析显示重新校准的PREDICT在最大阈值概率范围内比9分和BRAIN模型更具临床实用性;纳入CT血管造影点征的PREDICT和9分评分优于不含点征的BRAIN评分。作者认为这些模型足以进行风险分层,但区分度和校准最多为中等水平,仍有改进空间。
要点
- 在新加坡123例自发性脑出血前瞻队列中,重新校准的PREDICT评分整体表现最佳,R2为0.26、Brier评分为0.14。
- 决策曲线分析显示,重新校准的PREDICT评分在最大阈值概率范围内比9分和BRAIN模型更具临床实用性。
- 纳入CT血管造影点征的PREDICT和9分评分优于不含点征的BRAIN评分,支持CT血管造影点征作为脑出血后结局的预测因子。
- 作者认为三种模型足以进行风险分层,但区分度和校准最多为中等水平,仍有改进空间。
适用人群与场景
- 新加坡一家三级医院(认证卒中中心)前瞻招募的123例自发性脑出血患者。
研究设计与关键结果
- 研究类型为前瞻性队列外部验证,样本量123例自发性脑出血患者,来自新加坡一家三级医院(认证卒中中心)。
- 对所有模型进行逻辑重新校准,获得更新的校准斜率和截距。
- 基于赤池信息准则和c统计量构成的新矩阵,重新校准的PREDICT评分在三种模型中表现最佳。
- PREDICT评分的R2最高(0.26),Brier评分最低(0.14)。
- 决策曲线分析显示,重新校准的PREDICT评分在最大阈值概率范围内比9分和BRAIN模型更具临床实用性。
- 纳入CT血管造影点征的PREDICT和9分评分优于不含点征的BRAIN评分。
证据类型、等级与局限
- 证据类型:前瞻性队列外部验证研究。
- 作者结论:PREDICT评分在研究队列中基于所用表现指标表现最佳;模型足以进行风险分层,但区分度和校准最多为中等水平,仍有改进空间。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在亚洲多族裔自发性脑出血患者中,PREDICT评分可用于血肿扩大风险分层,但区分度和校准仅为中等水平。
- 作者认为,CT血管造影点征可作为脑出血后结局的预测因子。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hematoma expansion (HE) occurs in approximately one-third of patients with intracerebral hemorrhage (ICH) and is known to be a strong predictor of neurological deterioration as well as poor functional outcome. This study aims to externally validate three risk prediction models of HE (PREDICT, 9-point, and BRAIN scores) in an Asian population.
METHODS: A prospective cohort of 123 spontaneous ICH patients admitted to a tertiary hospital (certified stroke center) in Singapore was recruited. Logistic recalibrations were performed to obtain updated calibration slopes and intercepts for all models. The discrimination (c-statistic), calibration (Hosmer-Lemeshow test, le Cessie-van Houwelingen-Copas-Hosmer test, Akaike information criterion), overall performance (Brier score, R2), and clinical usefulness (decision curve analysis) of the risk prediction models were examined.
RESULTS: Overall, the recalibrated PREDICT performed best among the three models in our study cohort based on the novel matrix comprising of Akaike information criterion and c-statistic. The PREDICT model had the highest R2 (0.26) and lowest Brier score (0.14). Decision curve analyses showed that recalibrated PREDICT was more clinically useful than 9-point and BRAIN models over the greatest range of threshold probabilities. The two scores (PREDICT and 9-point) which incorporated computed tomography (CT) angiography spot sign outperformed the one without (BRAIN).
CONCLUSIONS: To our knowledge, this is the first study to validate HE scores, namely PREDICT, 9-Point and BRAIN, in a multi-ethnic Asian ICH patient population. The PREDICT score was the best performing model in our study cohort, based on the performance metrics employed in this study. Our findings also showed support for CT angiography spot sign as a predictor of outcome after ICH. Although the models assessed are sufficient for risk stratification, the discrimination and calibration are at best moderate and could be improved.
参考来源
- Lim JX, Han JX, See AAQ, et al. External Validation of Hematoma Expansion Scores in Spontaneous Intracerebral Hemorrhage in an Asian Patient Cohort. Neurocrit Care. 2019. PMID: 30377910. doi:10.1007/s12028-018-0631-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。